← Browse by Condition
Medical Condition
ovarian clear cell adenocarcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3, Phase 2
NCT04575935 Phase 3
Recruiting
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Enrollment
580 pts
Location
United States, Canad...
Sponsor
M.D. Anderson Cancer Center
NCT04919629 Phase 2
Recruiting
APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion
Enrollment
60 pts
Location
United States
Sponsor
Roswell Park Cancer Institute